title: Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.
authors.forename: P
authors.initials: P
authors.lastname: Rossi
authors.forename: A L
authors.initials: AL
authors.lastname: Demoux
authors.forename: B
authors.initials: B
authors.lastname: Granel
authors.forename: D
authors.initials: D
authors.lastname: Bagnères
authors.forename: S
authors.initials: S
authors.lastname: Bonin-Guillaume
authors.forename: Y
authors.initials: Y
authors.lastname: Frances
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007166:Immunosuppressive Agents; D000069283:Rituximab